Estimated number of adult survivors of childhood cancer in United States with cancer‐predisposing germline variants
Pediatric Blood & Cancer2019Vol. 67(2), pp. e28047–e28047
Citations Over TimeTop 10% of 2019 papers
Carmen L. Wilson, Zhaoming Wang, Qi Liu, Matthew J. Ehrhardt, Roya Mostafavi, John Easton, Heather L. Mulder, Dale J. Hedges, Shuoguo Wang, Michael Rusch, Michael N. Edmonson, Shawn Levy, Jennifer Q. Lanctot, Kelsey Currie, Matthew Lear, Aman Patel, Yadav Sapkota, Russell J. Brooke, Wonjong Moon, Ti‐Cheng Chang, Wenan Chen, Chimene Kesserwan, Gang Wu, Kim E. Nichols, Melissa M. Hudson, Jinghui Zhang, Leslie L. Robison, Yutaka Yasui
Abstract
Given the increasing number of childhood cancer survivors in the United States, clinicians should counsel survivors regarding their potential genetic risk, consider referral for genetic counseling and testing, and, as appropriate, implement syndrome-specific cancer surveillance or risk-reducing measures.
Related Papers
- → The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?(2021)25 cited
- → Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies(2022)23 cited
- → Genetic Testing Utilization: Discrepancies Between Somatic and Germline Results in Patients With Cancer Reviewed at the UW Health Precision Medicine Molecular Tumor Board(2024)2 cited
- → “I need to know if I’m going to die young”: Adolescent and young adult experiences of genetic testing for Li–Fraumeni syndrome(2020)19 cited
- → Genetische Prädisposition für Krebserkrankungen im Kindesalter(2018)7 cited